{"id":"W4406971619","doi":"10.1200/go-24-00464","title":"Oral Cyclophosphamide for Patients With Metastatic Castration-Resistant Prostate Cancer in a Scenario of Limited Health Care Resources","year":2025,"lang":"en","type":"article","venue":"JCO Global Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"NOSM University","funders":"Genentech; Exelixis; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Docetaxel; Prostate cancer; Cyclophosphamide; Regimen; Prostate-specific antigen; Oncology; Internal medicine; Cancer; Prostate; Urology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001773389,0.0001007267,0.0002233983,0.0005067695,0.0002720485,0.0003335359,0.0002162354,0.0002102486,0.001283774],"category_scores_gemma":[0.0009785076,0.00006804943,0.0001665182,0.0007127601,0.0001875083,0.0002177702,0.0002507905,0.0002693474,0.0001231151],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004315074,"about_ca_system_score_gemma":0.001071649,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00400047,"about_ca_topic_score_gemma":0.01311145,"domain_scores_codex":[0.9998782,0.00003155186,0.00001756541,0.0000174317,0.00003212897,0.00002309365],"domain_scores_gemma":[0.9994288,0.00006250603,0.0003388262,0.00001359765,0.00002691712,0.0001292899],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004255794,0.0001432375,0.9347983,0.0005409084,0.00007276661,0.00759365,0.0001540263,0.0001793561,0.001279262,0.0001449767,0.0025147,0.05215323],"study_design_scores_gemma":[0.0001614323,0.0008221549,0.9557857,0.0007195881,0.0001768945,0.03002604,0.0007364255,0.0007215563,0.0007003902,0.0003022835,0.009828779,0.00001878288],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9811724,0.01256945,0.0003334947,0.001641584,0.00004659565,0.0001029768,0.0005027848,0.00002021491,0.003610519],"genre_scores_gemma":[0.9959044,0.003027798,0.0002534619,0.000285375,0.00007082292,0.000016001,0.0002615913,0.000002397797,0.0001782081],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00400047,"threshold_uncertainty_score":0.007954419,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01873738713748683,"score_gpt":0.3784184127034239,"score_spread":0.3596810255659371,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}